COVID-19 Frontline - A New Light in the Darkness: Therapies Recently Granted Emergency Use Authorizations for Patients with COVID-19
A Light in the Darkness: New Virus-neutralizing Monoclonal Antibodies and Other Point-of-Care Therapies Recently Granted Emergency Use Authorizations for Patients with COVID-19
This program provides a perspective on the ever-changing management of patients with COVID-19. It features case studies to encourage retention of the lessons and provide new perspectives on the management of patients during the COVID-19 pandemic. This program will focus on optimizing outcomes for hospitalized and non-hospitalized patients with COVID-19 through the use of novel agents authorized for emergency use.
These troubling times require communication among specialists and primary care. In this COVID-19 ask the expert the faculty will discuss the most pressing and frequently asked questions about this disease and its complications.